iShares U.S. Pharmaceuticals ETF (IHE) |
| 101.27 -0.92 (-0.9%) 09-10 16:00 |
| Open: | 102.44 |
| High: | 102.44 |
| Low: | 101.2 |
| Volume: | 214,165 |
| Market Cap: | 1,146(M) |
| PE Ratio: | 28.36 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 108.66 |
| Resistance 1: | 105.81 |
| Pivot price: | 104.69 |
| Support 1: | 101.20 |
| Support 2: | 84.20 |
| 52w High: | 108.66 |
| 52w Low: | 69.02 |
The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Thu, 10 Sep 2026
iShares US Pharmaceuticals ETF faces near-term risks despite long-term growth potential. - pluang.com
Thu, 10 Sep 2026
IHE: Large-Cap Pharma Cools After A Hot Summer (NYSEARCA:IHE) - Seeking Alpha
Tue, 08 Sep 2026
Does iShares Pharma ETF Offer Superior Returns to Invesco's Equal Weight Healthcare Fund? - The Motley Fool
Tue, 08 Sep 2026
Is the iShares Pharmaceuticals ETF or iShares Healthcare ETF the Better Fund for 2026? - The Motley Fool
Tue, 08 Sep 2026
Is the iShares Pharmaceuticals ETF or iShares Healthcare ETF the Better Fund for 2026? - Yahoo Finance
Sat, 22 Aug 2026
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - Eastern Progress
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
